Acupuncture to reduce symptoms of lymphoedema in women recovering from breast cancer
Can acupuncture compared with usual care reduce symptoms of lymphoedema in women recovering from breast cancer: a feasibility study
University of Western Sydney
20 participants
Jul 14, 2012
Interventional
Conditions
Summary
This study aims to determine whether acupuncture can reduce symptoms of lymphoedema (chronic swelling) in women recovering from breast cancer. Who is it for? You may be eligible to join this study if you are aged 18 years or more and have had chronic swelling (lymphoedema) on one arm present for at least 6 months following treatment for breast cancer. Trial details Participants in this trial will be randomly (by chance) allocated to one of two groups. Participants in one group will receive 12 acupuncture treatments over a period of 8 weeks in a schedule of twice weekly for four weeks then once weekly for four weeks. Participants in the other group will continue to receive their usual care and will not undergo any acupuncture treatment. Participants will be assessed at regular intervals to determine how lymphoedema is affected by acupuncture over a course of treatment. This study will also determine the feasibility and safety of acupuncture.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Acupuncture. Twelve treatments will be administered over 8 weeks. Twice weekly for four weeks and weekly for four weeks. Treatment wll be administered over 45 minutes. The acupuncture points used include a selection of three points from Ren 12, 3, 2, LI15, TH4, LU5, LI4. ST36, SP9, SP6, and additional points from the subjects differential diagnosis.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12612000607875